PHASE 3 STUDY OF IBRUTINIB IN COMBINATION WITH RITUXIMAB VERSUS PLACEBO IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH TREATMENT-NAÏVE FOLLICULAR LYMPHOMA (PERSPECTIVE)
Rule, S., Flinn, I.W., Fowler, N., Chen, R., Kwei, L., Beaupre, D.M., Chu, A.D., Gordon, L.I.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2440_12
Date:
June, 2017
File:
PDF, 105 KB
english, 2017